Organon & Co. (NYSE:OGN – Get Rating) announced a quarterly dividend on Thursday, February 16th, Zacks reports. Stockholders of record on Monday, February 27th will be paid a dividend of 0.28 per share on Thursday, March 16th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 4.50%. The ex-dividend date of this dividend is Friday, February 24th.
Organon & Co. Stock Performance
→ Fed’s Shocking New Plan to Control Your Money (From Weiss Ratings)
Organon & Co. stock opened at $24.87 on Friday. The stock has a 50-day simple moving average of $29.30 and a 200-day simple moving average of $27.74. The company has a market capitalization of $6.33 billion, a P/E ratio of 6.28 and a beta of 0.74. Organon & Co. has a fifty-two week low of $22.88 and a fifty-two week high of $39.47.
Organon & Co. (NYSE:OGN – Get Rating) last issued its earnings results on Thursday, February 16th. The company reported $0.81 earnings per share for the quarter, missing the consensus estimate of $0.85 by ($0.04). The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Organon & Co. had a negative return on equity of 114.90% and a net margin of 16.07%. The company’s quarterly revenue was down 7.4% compared to the same quarter last year. During the same period last year, the business posted $1.37 earnings per share. As a group, analysts forecast that Organon & Co. will post 5.1 earnings per share for the current year.
Hedge Funds Weigh In On Organon & Co.
Several large investors have recently bought and sold shares of the business. Wellington Shields Capital Management LLC bought a new stake in shares of Organon & Co. during the fourth quarter worth $27,000. Geneos Wealth Management Inc. acquired a new stake in Organon & Co. in the 1st quarter worth about $131,000. Money Concepts Capital Corp increased its holdings in Organon & Co. by 122.0% in the 4th quarter. Money Concepts Capital Corp now owns 4,598 shares of the company’s stock valued at $128,000 after buying an additional 2,527 shares during the period. Lazard Asset Management LLC increased its holdings in Organon & Co. by 67.9% in the 4th quarter. Lazard Asset Management LLC now owns 4,945 shares of the company’s stock valued at $138,000 after buying an additional 2,000 shares during the period. Finally, Wellington Shields & Co. LLC bought a new stake in shares of Organon & Co. during the 4th quarter valued at approximately $187,000. 75.74% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, Morgan Stanley decreased their price target on shares of Organon & Co. from $27.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Friday, November 4th.
Organon & Co. Company Profile
Organon & Co, a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women’s health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Organon & Co., you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Organon & Co. wasn’t on the list.
While Organon & Co. currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Elon Musk’s Next Move
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Source: marketbeat.com
